Emerging Noninvasive Biomarkers for Early Detection of Alzheimer's Disease
item_84871652602.pdf (1.731Kb)Abstract
Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsychological testing. The development of accurate, easy to use and inexpensive biological markers for AD is a long-standing aspiration for researchers and the medical community. Here we describe some of the recent advances in the field of biomarkers, both in cerebrospinal fluid (CSF) and in peripheral blood. © 2012 IMSS.
Indexation
Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/165885
DOI: 10.1016/j.arcmed.2012.10.013
ISSN: 01884409
18735487
Quote Item
Archives of Medical Research, Volumen 43, Issue 8, 2018, Pages 663-666
Collections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile